Anticonvulsant potential of tolfenamic acid in pentylenetetrazol-induced acute symptomatic seizures in male wistar rats
The Journal of Physiological Sciences · 2026-11 · 76 (3) · 100109
DOI: 10.1016/j.jphyss.2026.100109 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physiological Sciences, 2026-11. Verfasst von Saghi Hakimi Naeini und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Sciences and Marine Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
OBJECTIVES: Epilepsy is a neurological disorder characterized by recurrent seizures, posing significant challenges to patients' quality of life. Novel therapeutic agents are continuously sought to enhance seizure management. This study investigates the anticonvulsant potential of tolfenamic acid in a model of pentylenetetrazol (PTZ)-induced acute symptomatic seizures in male Wistar rats. METHODS: Male Wistar rats were administered tolfenamic acid prior to PTZ-induced seizure induction. The anticonvulsant effects were evaluated by assessing seizure onset, severity, and duration. Biochemical assays were performed to measure oxidative stress and inflammatory markers. RESULTS: Tolfenamic acid treatment significantly delayed the onset of seizures and reduced both seizure severity and duration compared to the negative control group (p < 0.05). Biochemical analysis revealed a notable modulation of oxidative stress and inflammatory pathways in rats treated with tolfenamic acid, indicating its neuroprotective properties (p < 0.05). CONCLUSIONS: The findings demonstrate the significant anticonvulsant and neuroprotective properties of tolfenamic acid in a PTZ-induced seizure model. By delaying seizure onset, reducing severity and duration, and modulating oxidative stress and inflammation, tolfenamic acid shows promise as a potential therapeutic agent for seizure management. Additional clinical trials are necessary to confirm these results in human populations and to investigate the potential of tolfenamic acid as a new treatment for epilepsy and related disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Animal Sciences and Marine Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.
- Department of Animal Sciences and Marine Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran. Electronic address: ab_hosseini@sbu.ac.ir.
Zitieren
APA
Hakimi Naeini, S., Azizi, V., & Hosseini, A. (2026). Anticonvulsant potential of tolfenamic acid in pentylenetetrazol-induced acute symptomatic seizures in male wistar rats. The Journal of Physiological Sciences, 76(3), 100109. https://doi.org/10.1016/j.jphyss.2026.100109
Vancouver
Hakimi Naeini S, Azizi V, Hosseini A. Anticonvulsant potential of tolfenamic acid in pentylenetetrazol-induced acute symptomatic seizures in male wistar rats. The Journal of Physiological Sciences. 2026;76(3):100109. doi:10.1016/j.jphyss.2026.100109
BibTeX
@article{HakimiNaeini2026,
author = {Hakimi Naeini, Saghi and Azizi, Vahid and Hosseini, Abdolkarim},
title = {Anticonvulsant potential of tolfenamic acid in pentylenetetrazol-induced acute symptomatic seizures in male wistar rats},
journal = {The Journal of Physiological Sciences},
year = {2026},
volume = {76},
number = {3},
pages = {100109},
doi = {10.1016/j.jphyss.2026.100109}
}
EUVIMED